论文部分内容阅读
大剂量尿激酶(UK)治疗急性心肌梗塞(AMI)是目前国内外常用治疗方法。我科自1988年以来,对具有应用 UK 适应证的38例患者均采用了大剂量 UK(120万 u)治疗,其中4例最后诊断排除 AMI。现分别报告如下。病例摘要例1:男患,51岁,因持续性上腹痛伴恶心、大汗1小时于1989年1月31日入院。查体:体温35.8℃,脉搏50次/分,呼吸20次/分,血压14/9kPa,心率50次/分,律齐。心电图(ECG)示:窦缓,Ⅱ°窦房传导阻滞,Tv_1～v_5高耸,STv_1～v_5抬高,J 点上移。诊断:冠心病,AMI?。予 UK50万 u加5%葡萄糖40ml 静推,继以
High-dose urokinase (UK) for the treatment of acute myocardial infarction (AMI) is currently used at home and abroad. Since 1998, our department has been using high-dose UK (1.2 million u) of 38 patients with an indication of the use of the UK, with 4 of the final diagnoses excluding AMI. Now separately reported as follows. Case Summary Example 1: Male patient, 51 years old, admitted to hospital on January 31, 1989 due to persistent upper abdominal pain with nausea and sweating for 1 hour. Physical examination: body temperature 35.8 ℃, pulse 50 beats / min, breathing 20 beats / min, blood pressure 14 / 9kPa, heart rate 50 beats / min, law Qi. Electrocardiogram (ECG): sinus slow, Ⅱ ° sinoatrial block, Tv_1 ~ v_5 towering, STv_1 ~ v_5 elevation, J point up. Diagnosis: coronary heart disease, AMI? To UK50 million u plus 5% glucose 40ml static push, followed by